UPDATED: New York State Conditionally Approves Natera to Offer Expanded Panorama Test | GenomeWeb

The story has been updated to clarify that the New York State approval includes the regular Panorama panel and 22q11.2 deletion syndrome.

NEW YORK (GenomeWeb) – Prenatal testing firm Natera today said that it has received conditional approval from New York State to offer the expanded Panorama non-invasive prenatal test to residents in the state.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.